Modular Medical, Inc.·4

Jul 1, 1:21 PM ET

FRANK MORGAN C. 4

4 · Modular Medical, Inc. · Filed Jul 1, 2026

Research Summary

AI-generated summary of this filing

Updated

Modular Medical (MODD) 10% Owner Frank Morgan Receives Award

What Happened

  • Frank Morgan C., a 10% owner of Modular Medical, received two grants/awards on 2026-06-30: 62 derivative shares and 250 derivative shares (total = 312). The filings list the transactions as awards/grants (code A). No exercise price or dollar value is provided (listed as N/A). Footnote states the options were granted under the issuer’s Outside Director Compensation Plan and were fully vested and exercisable on the grant date, so the recipient can exercise them immediately.

Key Details

  • Transaction date: 2026-06-30; Filing date: 2026-07-01 (appears timely).
  • Transaction type: Awards/Grants of derivative securities (options); prices listed as N/A in the filing.
  • Quantity: 62 and 250 derivative share awards (total 312).
  • Shares owned after transaction: Not specified in the provided summary (the filing’s column 9 info was not included here).
  • Notable footnotes:
    • F1: Options granted under the Outside Director Compensation Plan; fully vested and exercisable on grant date.
    • F2: Column 9 reports total beneficial ownership for a given "class" of derivative security; options with different exercise prices or vesting terms may be reported separately.
  • Filing timeliness: Reported within one business day after the transaction date, which appears timely for a Form 4.

Context

  • These were awards (compensation) rather than open-market purchases or sales. Awards to directors or large shareholders are often routine compensation and do not, by themselves, indicate a buy/sell signal. Because exercise prices and other economic terms were not disclosed in the provided data, the immediate monetary value of the awards cannot be determined from this filing alone.

Insider Transaction Report

Form 4
Period: 2026-06-30
FRANK MORGAN C.
Director10% Owner
Transactions
  • Award

    Option to purchase common stock

    [F1][F2]
    2026-06-30+6262 total
    Exercise: $4.88From: 2026-06-30Exp: 2036-06-30Common Stock (62 underlying)
  • Award

    Option to purchase common stock

    [F1][F2]
    2026-06-30+250312 total
    Exercise: $4.88From: 2026-06-30Exp: 2036-06-30Common Stock (250 underlying)
Footnotes (2)
  • [F1]The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.
  • [F2]In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."
Signature
Morgan C. Frank By: /s/ Morgan C. Frank|2026-07-01

Documents

1 file
  • 4
    ownership.xmlPrimary